Our website uses cookies so that we can improve your experience. Learn more about our cookies


Program Plus 12-22kg 6 tablets

Prevention of flea infestations, prophylaxis of heartworm disease and / or treatment of infections by adult gastrointestinal nematodes.

Ref. 7427971
Tax included

Medicinal product subject to veterinary prescription.

Shipping from:

 Calculate Shipping Cost


Program Plus is indicated for dogs, from two weeks of age and / or 1 kg of body weight, it is indicated for the prevention of flea infestations, in the prophylaxis of heartworm and / or treatment of infections by adult gastrointestinal nematodes such as : Toxocara canis, Toxascaris leonina, Ancylostoma caninum and Trichuris vulpis.

Program Plus is composed of the active substances milbemycin oxime and lufenuron being available in 3 presentations. It is intended for oral administration, according to the dog's weight, along with the main meal, at monthly intervals, according to the following table:

5 to 11Kg = 1 pill of Program Plus 5.75 / 115 mg
12 to 22 kg = 1 pill of Program Plus 11.5 / 230 mg
23 to 45 kg = 1 pill of Program Plus 23/460 mg

For animals weighing over 45 kg, a combination of tablets should be administered, in order to always maintain a minimum indicated dose level.

Monthly, orally, together with the main meal

Do not use in dogs less than two weeks of age or less than 5 kg of body weight.

Side effects:
Animals with a high filarial infestation, as they have a large number of circulating microfilariae, can sometimes present a moderate and transient hypersensitivity action, showing the following symptoms: vomiting, excessive salivation, pale mucous membranes and membranes, breathing difficulty. These reactions are associated with the release of proteins from dead or dying microfilariae, they are not toxic effects related to the product.

Gestation and Lactation:
PROGRAM PLUS does not cause any alteration in reproductive or fetal function, no toxic neonatal effect has been reported in dogs that have received the product as monotherapy.

As it is a veterinary medicine subject to medical prescription, we request that it be sent to the email: [email protected]